ThermoGenesis Provides Update on Fiscal 2009 Results
RANCHO CORDOVA, Calif., Aug. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier of innovative products for processing and storing adult stem cells, said today that it expects revenues for the fiscal year ended June 30, 2009, will be in the range of...
GeoVax Labs, Inc. Provides Clinical Studies Update
ATLANTA, Aug. 5 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based HIV/AIDS vaccine development company, today announced updates on its ongoing and planned human clinical trials.
"We have two main areas of focus for our HIV/AIDS vaccine - ...
Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today reported financial results for the second quarter ended June 30, 2009, and provided a corporate update.
Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 4 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.
(NYSE AMEX: SVA ), a leading provider of vaccines in China, announced today
that the clinical trial of its A/H1N1 influenza vaccine is proceeding well.
All of the volunteers received their first shot of the vaccine and, during the
Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
BEIJING, Aug. 3 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE AMEX: SVA ),
a leading provider of vaccines in China, announced today that the clinical
trial of its A/H1N1 influenza vaccine is proceeding well. All of the
volunteers have received their first shot of the vaccine and, during th...
Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
SAN DIEGO, Calif., July 28 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) and its subsidiary Tissue Repair Company (TRC) today provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy...
Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of convertible debt. The company also retired other ...
China Clean Energy Provides Business Update
FUQING CITY, China, July 7 /PRNewswire-Asia-FirstCall/ -- China Clean
Energy Inc. (OTC Bulletin Board: CCGY) ("China Clean Energy", the "Company"),
a producer of biodiesel fuel and environmentally-friendly specialty chemical
products made from renewable resources in The People's Republic of Ch...
MEDS World, LLC Provides Multiple Environments with Designed Solutions - Wherever People Congregate, MEDS Odor Elimination Solutions Offer Eco-Friendly, Odor-Free Air
In 2008, Bruce Hecht and Chase Walker formed MEDS World, LLC, launching innovative odor elimination, exterior plastic trim and headlight restoration products to the Automotive, RV and Marine industries. Bruce and Chase have combined over fifty years of management experiences, in a myriad of indus...
New Probiotics Bacteria Supplier ProbioFerm, LLC Provides the Highest Quality Beneficial Bacteria Available for Product Development
Although recently established, new Probiotics bacteria supplier ProbioFerm, LLC pulls from a thoroughly experienced team to provide the highest possible quality bacteria available. The unique private label manufacturing company serves animal feed and agriculture businesses, functioning as a valu...
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
AURORA, Ontario, June 15 /PRNewswire/ -- Helix BioPharma Corp. ("Helix" or the "Company"), (TSX, FSE: "HBP") today announced its product development progress, quarterly highlights and financial results for the third quarter of fiscal 2009, ended April 30, 2009.
THIRD QUARTER HIGHLIGHTS AND P...
NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
20-Patient Study to Evaluate FDA-Approved Topical Anesthetic Pretreatment
SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ) announced today that the U.S. Food and Drug Administration (FDA) agreed to its proposed study to evaluate Qutenza(TM) in patients w...
PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
INCLINE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced revenue guidance for the second quarter ended June 30, 2009 of approximately $125 million, as compared with $106 million for the second quarter of 2008. The increase is due pr...
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Cimzia(R) shows duration of response up to week 26 in moderate to severe Crohn's patients who failed the intravenous infusion treatment infliximab.
CHICAGO, June 1 /PRNewswire/ -- New data from the WELCOME study presented by UCB at the Digestive Disease Week meeting demonstrate that Cimzia(R)...
OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
Webcast at 7:10 p.m. Eastern Time Today
BOTHELL, WA, and VANCOUVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) today announced the final results of a Randomized Phase 2 Trial presented during an oral presentation at the American Society of Clinical Oncol...
Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
way of integrating and sustaining positive change, increasing wellness
WASHINGTON, May 28 /PRNewswire-USNewswire/ -- In today's uncertain times, increased stress can wreak havoc on a body's systems. Now, a new emerging wellness, growth and behavioral change paradigm helps indiv...
Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
NASHVILLE, Tenn., May 18 /PRNewswire/ -- Cumberland Pharmaceuticals announced today the launch of an online in-service program for hospitals using Acetadote (acetylcysteine) Injection , the company's intravenous treatment for acetaminophen overdose.
Resverlogix Provides Quarterly Update
Alzheimer's disease biomarker assessment to be added to the
Phase 1b/2a trial
TSX Exchange Symbol: RVX
CALGARY, April 28 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or "Company") (TSX:RVX) is pleased to provide a corporate update on activities as well as an interi...
China Sky One Medical, Inc. Provides Update on Filing Form 10-K
HARBIN, China, April 7 /PRNewswire-Asia-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a
leading fully integrated pharmaceutical company producing
over-the-counter drugs in the People's Republic of China ("PRC"), today
announced that an ...
Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today released the following letter from its Lead Independent Director, James N. Wilson, providing shareholders with an update on recent developments:
Dear Fellow Amylin Shareholder:
As Lead Indep...
US Oncology Provides Full Service Management of Clinical Trials
HOUSTON, April 2 /PRNewswire/ -- US Oncology , the nation's foremost cancer treatment and research network, has established US Oncology Clinical Development (USOCD), a full service contract research organization (CRO).
USOCD formalizes many of the services that US Oncology Resear...
SemBioSys provides update on insulin program
CALGARY, April 1 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, provides
an update on its proprietary plant-produced recombinant human insulin program. In December 2008, SemBioSys announced that MannKind C...
Cochlear Americas Provides Support for Cochlear Implant Recipients to Pursue Higher Education
Company Announces 2009 Graeme Clark Scholarship Winners
DENVER, March 30 /PRNewswire/ -- Cochlear Americas, the world's leader in advanced hearing technologies, today announced the winners of the 2009 Graeme Clark Scholarship awards. Since 2002, the Graeme Clark Cochlear Scholarship Foundatio...
Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure
SAN FRANCISCO, March 27 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a leading company in the development of novel therapeutics for heart failure patients, announced today that, in the course of reviewing the Investigational New Drug (IND) application materials that Nile ...
Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
- Conference Call Today at 4:30 p.m. Eastern Time -
SAN FRANCISCO, March 16 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today reported on its corporate progress and financial results for the fourth quarter and year ended December 31, 2008.
"We had a very productive ...
Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
WASHINGTON, March 12 /PRNewswire-FirstCall/ -- Proposed legislation that creates a regulatory framework to guide the approval of the first biogeneric medicines represents a critical step forward in providing more affordable treatment for millions of Americans suffering from chronic and complex con...
OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
Conference Call on Wednesday, March 11, 2009 at 4:30 p.m. Eastern Time
BOTHELL, WA, and VANCOUVER, March 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ), today announced its fourth quarter and fiscal year 2008 financial results, rev...
FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product
- Agency Supports Company's Production and Clinical and Preclinical Plans for DXL625 -
- Live Teleconference Scheduled with Leadership and Scientific Team for March 04, 2009 -
BRITISH COLUMBIA, Canada March 3 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc. (Toronto Stock Exchange: ...
In Analyst Interview, Cord Blood America Provides Details of Special Shareholder Meeting
SANTA MONICA, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and internati...
Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM)
SAN DIEGO, Feb. 18 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a private,
specialty pharmaceutical company, announced that the U.S. Food & Drug
Administration (FDA) has provided a target date of July 15, 2009 for
completion of its review of the NDA for Sumavel DosePro (sumatriptan
Sigma-Aldrich (Nasdaq: SIAL) Reports Fourth Quarter Diluted EPS of $0.68. Ends 2008 With Record Sales and Earnings and Raises Quarterly Cash Dividend by 11.5%. Provides Outlook for 2009.
ST LOUIS, Feb. 11 /PRNewswire-FirstCall/ -- Sigma-Aldrich, a leading Life
Science and High Technology company, reported that its fourth quarter 2008
diluted EPS grew by 6% to $0.68 from $0.64 in the same quarter of 2007.
Reported sales of $510 million in the fourth quarter 2008 declined...
ADVENTRX Provides Update on Strategic Transaction Process
SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
(NYSE Alternext US: ANX) announced today that it has received written
indications of interest from numerous companies representing a range of
strategic transactions. The Company currently is evaluating all proposals a...
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced financial results for the fourth quarter and year ended December 31, 2008.
Fourth Quarter 2008 Financial Results
For the three months ended December 31, 2008, the Compan...
New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
CHAPEL HILL, N.C., Feb. 5 /PRNewswire/ -- In today's tough economy,
maintaining operational efficiencies remains key, even while focusing on
strategy and tactics to drive growth and profitability. In an effort to
better understand the resources dedicated by biopharmaceutical companies to
OncoGenex Provides Update on Two-Year Survival Data from Ongoing Phase 1/2 Clinical Trial of OGX-011 in Non-Small Cell Lung Cancer
BOTHELL, WA, and VANCOUVER, Feb. 4 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) today announced the two-year survival rate from a Phase 1/2 clinical trial of OGX-011 in combination with first-line chemotherapy for the treatment of advanced non-small cell lung cancer (...
Bluegiga Provides Health Device Profile for its Bluetooth OEM Modules
CONTINUA WINTER SUMMIT and TOKYO, February 4 /PRNewswire/ -- Bluegiga
announced today that its OEM Bluetooth modules are now available with
Bluetooth Health Device Profile (HDP). The Health Device profile is
integrated into Bluegiga's iWRAP firmware, running inside the Bluegiga
Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
REDWOOD CITY, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Genomic Health,
Inc. (Nasdaq: GHDX ) today reported financial results and business progress for
the fourth quarter and year ended December 31, 2008.
Total revenue for the fourth quarter of 2008 increased to $31.2 million,
Vasogen Announces Sale of Patent Application and Provides Corporate Update
MISSISSAUGA, ON, Feb. 2 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS) today announced that it has sold a United States patent application and its related foreign counterparts for US$400,000. This device-based intellectual property has not been used to date in the Celacade System;...
New Study Provides Benchmarks for Winning Brand Team Management
CHAPEL HILL, N.C., Jan. 30 /PRNewswire/ -- New research has illustrated the dramatic impact effective structuring of brand teams can have on the success of pharmaceutical product sales before and after launch. In an effort to better understand the best practices in developing effective brand team...
CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN ), today reported its financial results for the fourth quarter and calendar year of 2008 and provided milestone and financial guidance for the first half of 2009.
During the three month period ended December...